Browsing by Subject "A61K 31/54"
Now showing items 1-3 of 3
-
Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-05-19)Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described. A therapeutically effective amount of a composition comprising compound PG-20N in a ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1994-09-06)A novel compound for the treatment and prevention of ocular and other types of inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1993-03-16)A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-101, is effective at both the early and late phases of inflammation. The compound is useful for the treatment of ...